Cardiac Rehab Effects in HFpEF
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Aug 6, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how exercise can help improve the quality of life for Veterans who have heart failure with preserved ejection fraction (HFpEF). HFpEF is a condition where the heart can pump blood well, but the body still struggles with exercise and fatigue. Researchers want to find out why this happens and how regular physical activity might help by focusing on the role of nerves in the muscles used during exercise. They hope that by better understanding these issues, they can show that exercise is a valuable way to treat this condition.
To be eligible for the trial, participants need to be adults with heart failure with preserved ejection fraction. The trial is currently recruiting individuals aged between 70 and 104 years, and it is open to all genders. Participants can expect to take part in a program that includes regular exercise, and researchers will assess how this impacts their ability to exercise and feel less fatigued. This study aims to provide valuable insights that could lead to better treatment options for Veterans facing these challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • heart failure with preserved ejection fraction
- Exclusion Criteria:
- • heart failure with reduced ejection fraction
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Markus Amann, PhD
Principal Investigator
VA Salt Lake City Health Care System, Salt Lake City, UT
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials